BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,758 | -20.5% | 35 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,212 | +40.4% | 35 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,575 | -29.5% | 35 | -31.4% | 0.00% | 0.0% |
| Q4 2022 | $2,234 | -25.5% | 51 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $3,000 | 0.0% | 51 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | -40.0% | 51 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $5,000 | -28.6% | 51 | -29.2% | 0.00% | -25.0% |
| Q3 2021 | $7,000 | +16.7% | 72 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $6,000 | -14.3% | 72 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $7,000 | +16.7% | 72 | +30.9% | 0.00% | 0.0% |
| Q4 2020 | $6,000 | +50.0% | 55 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | -42.9% | 55 | -42.7% | 0.00% | -20.0% |
| Q3 2019 | $7,000 | -30.0% | 96 | -8.6% | 0.01% | -28.6% |
| Q2 2019 | $10,000 | +25.0% | 105 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $8,000 | -11.1% | 105 | -5.4% | 0.01% | +50.0% |
| Q3 2018 | $9,000 | – | 111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |